Rik Gijsbers

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 7

Top Topics

Intellectual Disability

Binding Protein

Top Venues

Human gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Louise Medaer, Dries David, Maxime Smits, Elena Levtchenko, Maurilio Sampaolesi, Rik Gijsbers
Residual Cystine Transport Activity for Specific Infantile and Juvenile CTNS Mutations in a PTEC-Based Addback Model. Cells 13 (7) (2024)
Louise Medaer, Dries David, Maxime Smits, Elena Levtchenko, Maurilio Sampaolesi, Rik Gijsbers
Residual Cystine Transport Activity for Specific Infantile and Juvenile CTNS Mutations in a PTEC-Based Addback Model. Cells 13 (7) (2024)
Louise Medaer, Dries David, Maxime Smits, Elena Levtchenko, Maurilio Sampaolesi, Rik Gijsbers
Residual Cystine Transport Activity for Specific Infantile and Juvenile CTNS Mutations in a PTEC-Based Addback Model. Cells 13 (7) (2024)
Louise Medaer, Dries David, Maxime Smits, Elena Levtchenko, Maurilio Sampaolesi, Rik Gijsbers
Residual Cystine Transport Activity for Specific Infantile and Juvenile CTNS Mutations in a PTEC-Based Addback Model. Cells 13 (7) (2024)
Louise Medaer, Koenraad R P Veys, Rik Gijsbers
Current Status and Prospects of Viral Vector-Based Gene Therapy to Treat Kidney Diseases. Human gene therapy 35 (5-6) (2024)
Louise Medaer, Dries David, Maxime Smits, Elena Levtchenko, Maurilio Sampaolesi, Rik Gijsbers
Residual Cystine Transport Activity for Specific Infantile and Juvenile CTNS Mutations in a PTEC-Based Addback Model. Cells 13 (7) (2024)
Lenard S Vranckx, Jonas Demeulemeester, Zeger Debyser, Rik Gijsbers
Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras. PloS one 11 (10) (2016)